News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
317,950 Results
Type
Article (13843)
Company Profile (67)
Press Release (304040)
Section
Business (98441)
Career Advice (341)
Deals (16608)
Drug Delivery (45)
Drug Development (34722)
Employer Resources (63)
FDA (9391)
Job Trends (8160)
News (161732)
Policy (14734)
Tag
Academia (1396)
Africa (281)
Alabama (22)
Allergies (24)
Alliances (29615)
Alzheimer's disease (543)
Antibody-drug conjugate (ADC) (24)
Approvals (9364)
Arizona (38)
Artificial intelligence (34)
Asia (21376)
Australia (2759)
Bankruptcy (83)
Best Places to Work (6922)
Biosimilars (42)
C2C Services and Suppliers (37717)
California (499)
Canada (342)
Cancer (91)
Career advice (303)
Cell therapy (38)
China (39)
Clinical research (27633)
Collaboration (45)
Colorado (28)
COVID-19 (998)
Cystic fibrosis (35)
Data (16)
Diabetes (17)
Diagnostics (3082)
Diversity, equity & inclusion (23)
Drug pricing (24)
Earnings (31365)
Employer resources (55)
Europe (47918)
Events (47570)
Executive appointments (20)
FDA (9427)
Florida (71)
Funding (25)
Gene therapy (26)
GLP-1 (193)
Government (2160)
Healthcare (9797)
Hotbed/Location (219080)
Idaho (29)
Illinois (103)
Indiana (74)
Infectious disease (1001)
Inflammatory bowel disease (61)
Interviews (43)
IPO (7077)
Job creations (1272)
Job search strategy (282)
Kansas (45)
Layoffs (122)
Legal (2233)
Liver cancer (28)
Lung cancer (22)
Maine (27)
Management (17)
Manufacturing (31)
Maryland (223)
Massachusetts (261)
Medical device (8878)
Medtech (8880)
Mergers & acquisitions (9475)
Metabolic disorders (52)
Neuroscience (578)
New Jersey (48)
New York (53)
NextGen Class of 2024 (3192)
Non-profit (2406)
North Carolina (114)
Obesity (29)
Opinion (88)
Parkinson's disease (16)
Peanut (23)
Pennsylvania (34)
People (29334)
Phase I (8387)
Phase II (11490)
Phase III (10069)
Policy (25)
Postmarket research (939)
Preclinical (2972)
Rare diseases (46)
Real estate (3081)
Recruiting (24)
Regulatory (10723)
Reports (18)
Research institute (1370)
Resumes & cover letters (35)
South America (427)
Startups (2034)
Texas (48)
United States (1837)
Vaccines (144)
Washington State (42)
Weight loss (23)
Date
Today (40)
Last 7 days (327)
Last 30 days (1250)
Last 365 days (23358)
2024 (13365)
2023 (23582)
2022 (29469)
2021 (30917)
2020 (29018)
2019 (26277)
2018 (19822)
2017 (17966)
2016 (16708)
2015 (18692)
2014 (13226)
2013 (10523)
2012 (11187)
2011 (11222)
2010 (9420)
317,950 Results for "innovent biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Diabetes
Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval
Innovent Biologics’ dual GLP-1/glucagon receptor agonist mazdutide is also being developed for chronic weight management. China’s regulator accepted Innovent’s drug application for this indication in February 2024.
July 22, 2024
·
2 min read
·
Tristan Manalac
News
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals
July 16, 2024
·
7 min read
Deals
Advanced Biologics Elevates Biologic Innovations Through Merger with Isto Biologics.
Advanced Biologics (known commercially as Biologica Technologies), a California-based company known for their innovative biologic solutions, announced today their successful merger with Isto Biologics, a global leader in regenerative and autologous therapies.
October 18, 2023
·
3 min read
Business
GenSight Biologics Appoints William Monteith to its Board of Directors
GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced the appointment of William Monteith to its Board of Directors.
June 3, 2024
·
4 min read
BioMidwest
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial Intelligence program, named ADMAlytics.
February 21, 2024
·
5 min read
Biotech Bay
Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline
Innovent Biologics, Inc. provided interpretation and updates on clinical data from Mazdutide’s GLORY-1 study and its general biomedicine pipeline at an investor conference call on June 25.
June 27, 2024
·
9 min read
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Biotech Bay
Innovent Reports Oncology Pipeline Updates at Investor Meeting - June 19, 2024
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, provided updates on its oncology pipeline at an investor meeting.
June 18, 2024
·
9 min read
Biotech Bay
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA’s 84th Scientific Sessions
Innovent Biologics, Inc. announces that it will present multiple clinical study results of mazdutide at the American Diabetes Association’s® 84th Scientific Sessions in Orlando from June 21 -24.
June 11, 2024
·
5 min read
Drug Development
Innovent Presents the Results of the First Phase 3 Study of Mazdutide for Weight Management at the ADA’s 84th Scientific Sessions
Innovent Biologics, Inc. presents the key results of the first Phase 3 clinical trial of mazdutide in Chinese adults with overweight or obesity at the ADA Scientific Sessions 2024.
June 24, 2024
·
11 min read
1 of 31,795
Next
